Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract

By Winquist E.   Ernst D.S.   Jonker D.   Moore M.J.   Segal R.   Lockwood G.   Rodgers A.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1866-1871

Elsevier

Access to resources Recommend Favorite

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

Phase I Trial of Pegylated Liposomal Doxorubicin with Hyperthermic Intraperitoneal Chemotherapy in Patients Undergoing Cytoreduction for Advanced Intra-abdominal Malignancy

By Harrison Lawrence   Bryan Margarette   Pliner Lilian   Saunders Tracie  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1407-1413

Springer Publishing Company

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin in Salvage Chemotherapy for Multiple Myeloma Patients

By  

Current Cancer Therapy Reviews, Vol. 9, Iss. 1, 2013-01 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 793-796

Science Publishers

Access to resources Recommend Favorite